tiprankstipranks
Satellos Bioscience (TSE:MSCL)
TSX:MSCL
Canadian Market

Satellos Bioscience (MSCL) Income Statement

Compare
24 Followers

Satellos Bioscience Income Statement

Last quarter (Q3 2024), Satellos Bioscience's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Satellos Bioscience's net income was C$-9.05M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 25.00K
Gross Profit
C$ -8.82MC$ -3.73MC$ -119.92KC$ -48.16KC$ -1.26M
Operating Expenses
C$ 15.46MC$ 8.43MC$ 4.70MC$ 1.43MC$ 743.80K
Depreciation and Amortization
C$ 7.00KC$ 337.00KC$ 165.69KC$ 422.00C$ 734.00
EBITDA
C$ -15.71MC$ -8.09MC$ -4.60MC$ -1.61MC$ -2.00M
Operating Income
C$ -15.46MC$ -8.43MC$ -4.74MC$ -1.55MC$ -2.00M
Other Income/Expenses
C$ -426.00KC$ -2.89MC$ -8.86MC$ 349.79KC$ 217.22K
Pretax Income
C$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58MC$ -1.99M
Net Income
C$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58MC$ -1.99M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.18C$ -0.32C$ -0.64C$ -0.05C$ -0.18
Diluted EPS
C$ -0.18C$ -0.32C$ -0.64C$ -0.05C$ -0.18
Weighted Average Shares Outstanding
86.40M 35.68M 24.08M 32.87M 10.91M
Weighted Average Shares Outstanding (Diluted)
86.40M 35.68M 24.08M 32.87M 10.91M
Currency in CAD

Satellos Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis